The Effect of the Quran on Quality of Life and Quality of Sleep in Breast Cancer
ConditionBreast Carcinoma
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorArdahan University
About this trial
Objective: This study aims to investigate the effects of Quran on quality of life and sleep in patients receiving chemotherapy due to breast cancer.
Method: This study will be conducted with 40 patients with breast cancer receiving chemotherapy at Erzurum City Hospital Outpatient Chemotherapy Unit in a randomized controlled experimental design. Block randomization will be used in group assignment. The breast cancer patient identification form, European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Scale (QLQ-C30) and Pittsburg Sleep Quality Index (PSQI) will be used to collect research data. It is planned to collect research data with a total of four measurements during the application of the first, second, third and last protocols of chemotherapy.
Expected Results: As a result of the study, it is expected that Quran recitation will have a positive effect on quality of life and sleep in patients receiving chemotherapy due to breast cancer.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Having breast cancer
Being on chemotherapy
Being on a chemotherapy protocol every 21 days
Being over the age of 18
Disqualifiers
Having a hearing problem
Having an ear infection or any condition that prevents hearing
Having other types of cancer other than breast cancer
Trial design
Design model
Parallel
Treatments tested in this trial
Quran recital
Behavioralstandard treatment and care
standard treatment and care
Other interventionstandard treatment and care
Treatment groups
40 Participants
are divided into 2 treatment groupsGroup A: experimental groupExperimental treatment 1 intervention
Group B: control groupActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Scale (QLQ-C30), Version 3.0 (EORTC QLQ C-30)
The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Scale (QLQ-C30), Version 3.0 (EORTC QLQ C-30) will be used to assess quality of life. High general well-being and functional subscale scores indicate high quality of life.
Time frame
From registration to the end of treatment at week 12Secondary outcomes
1
Pittsburg Sleep Quality Index
The Pittsburgh Sleep Quality Index (PSQI) was used to assess sleep quality. A score of six or above indicates poor sleep quality.
Time frame
From registration to the end of treatment at week 12Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Ardahan University
Lead sponsor
Erzurum Technical University
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: